FDA: TV Ad Misbrands Erectile Dysfunction Drug Levitra
|
|
|
 |
Contributed by Jai A. Dennison| 17 April, 2005  03:04 GMT
 The woman in the Levitra TV ad says 'it's the best way to experience that difference,' suggesting that Levitra is superior to other treatments for ED. 'FDA is not aware of substantial evidence or substantial clinical experience demonstrating that Levitra is superior to other ED treatments.'
The Food and Drug Administration on Friday posted on its website a letter sent to
Bayer Pharmaceuticals Corporation, with copies to Schering Corporation and GlaxoSmithKline, over a TV ad promoting the impotence drug Levitra.
Following is the body of the letter:
This letter notifies Bayer Pharmaceuticals Corporation (Bayer) and, by copy, Schering Corporation (Schering) and GlaxoSmithKline (GSK), which market Levitra on behalf of Bayer, that the Division of Drug Marketing, Advertising, and Communications (DDMAC) has reviewed a direct-to-consumer television advertisement (TV ad) for Levitra |
|
|
|
|
|
|
|